| scholarly article | Q13442814 |
| P50 | author | Mihai Netea | Q24517868 |
| Guus Rimmelzwaan | Q55230980 | ||
| Johannes G van der Hoeven | Q92272544 | ||
| Frank van de Veerdonk | Q92689750 | ||
| Dimitri A Diavatopoulos | Q98614611 | ||
| P2093 | author name string | Peter Pickkers | |
| Matthijs Kox | |||
| Marien I de Jonge | |||
| Jelle Gerretsen | |||
| Eleonora J M Thijs | |||
| Janette C Rahamat-Langendoen | |||
| Joyce Schloesser | |||
| Rebecca M Koch | |||
| P2860 | cites work | Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change? | Q22306306 |
| A novel nonhuman primate model for influenza transmission | Q27302967 | ||
| Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae | Q30222430 | ||
| Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. | Q30367425 | ||
| Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. | Q30378132 | ||
| Translational research on influenza virus infection using a nonhuman primate model. | Q30383873 | ||
| Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses | Q30400432 | ||
| Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease | Q30402378 | ||
| Simultaneous infection with respiratory syncytial virus and other respiratory pathogens. | Q33440908 | ||
| Innate immune evasion strategies of influenza viruses | Q33646273 | ||
| Reactivation of multiple viruses in patients with sepsis | Q33740315 | ||
| Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity | Q34242721 | ||
| Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes | Q34300368 | ||
| Influenza virus infection in nonhuman primates | Q34423096 | ||
| Microbiota regulates immune defense against respiratory tract influenza A virus infection | Q34750186 | ||
| Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. | Q34801986 | ||
| The TLR4-TRIF pathway protects against H5N1 influenza virus infection | Q35665940 | ||
| Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study | Q35782019 | ||
| Localized mucosal response to intranasal live attenuated influenza vaccine in adults | Q36606611 | ||
| Chronic pulmonary LPS tolerance induces selective immunosuppression while maintaining the neutrophilic response. | Q36897545 | ||
| Commensal bacteria calibrate the activation threshold of innate antiviral immunity | Q36921389 | ||
| Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children | Q37040671 | ||
| Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination | Q37087674 | ||
| Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach | Q37233354 | ||
| Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. | Q37330594 | ||
| Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. | Q37712848 | ||
| Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults | Q37921281 | ||
| Evasion of influenza A viruses from innate and adaptive immune responses. | Q38061423 | ||
| Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older | Q38378644 | ||
| Trained immunity: A program of innate immune memory in health and disease. | Q38814347 | ||
| Patterns in Bacterial- and Viral-Induced Immunosuppression and Secondary Infections in the ICU. | Q38831953 | ||
| Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens | Q39625186 | ||
| Simultaneous infection with gammaherpes and influenza viruses enhances the host immune defense. | Q40872096 | ||
| Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. | Q41429025 | ||
| Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus | Q41847979 | ||
| Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses | Q41865771 | ||
| Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity. | Q42274879 | ||
| Respiratory pathogens in children with and without respiratory symptoms | Q43631415 | ||
| A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years | Q43956419 | ||
| Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus-associated encephalopathy-like changes in neonatal mice | Q45377207 | ||
| IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection | Q47371295 | ||
| Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. | Q51729193 | ||
| Development of endotoxin tolerance in humans in vivo. | Q51800120 | ||
| Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. | Q54331733 | ||
| Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. | Q54363308 | ||
| In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. | Q54737586 | ||
| Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung | Q59747080 | ||
| The Dynamics of Herpesvirus and Polyomavirus Reactivation and Shedding in Healthy Adults: A 14‐Month Longitudinal Study | Q61911882 | ||
| Mediator release after nasal airway challenge with allergen | Q70287869 | ||
| Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction | Q73646662 | ||
| Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer | Q83876420 | ||
| Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin* | Q84763519 | ||
| P921 | main subject | endotoxins | Q319997 |
| influenza vaccine | Q383260 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 1600 | |
| P577 | publication date | 2017-12-11 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo | |
| P478 | volume | 8 |
| Q64262471 | B-cell dynamics during experimental endotoxemia in humans |
| Q91719317 | Comparison of different lots of endotoxin and evaluation of in vivo potency over time in the experimental human endotoxemia model |
| Q92560672 | Frontline Science: Endotoxin-induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst |
| Q55312246 | Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected. |
Search more.